Related Experiment Videos
Multiple sclerosis: Mitoxantrone promotes differential effects on immunocompetent cells in vitro
Oliver Neuhaus1, Heinz Wiendl, Bernd C Kieseier
1Department of Neurology, Heinrich-Heine-Universität, Moorenstr. 5, 40225 Düsseldorf, Germany. oliver.neuhaus@uni-duesseldorf.de
Journal of Neuroimmunology
|September 21, 2005
Summary
Mitoxantrone suppresses immune cell proliferation and induces apoptosis in antigen-presenting cells like dendritic cells, offering a dual mechanism for treating multiple sclerosis (MS). This explains its efficacy in managing MS by targeting both lymphocytes and antigen presentation.
Area of Science:
- Immunology
- Pharmacology
- Neuroimmunology
Background:
- Mitoxantrone is an approved treatment for severe multiple sclerosis (MS).
- The precise mechanism of mitoxantrone's beneficial effects in MS remains unclear.
- Potential mechanisms include broad immunosuppression versus specific actions.
Purpose of the Study:
- To investigate the immunomodulatory effects of mitoxantrone on immune cells relevant to MS.
- To elucidate the specific cellular mechanisms underlying mitoxantrone's efficacy in multiple sclerosis.
Main Methods:
- Peripheral blood mononuclear cells (PBMCs) from MS patients and healthy donors were stimulated with or without mitoxantrone.
- Proliferation assays, cytokine production analysis, and apoptosis assays (annexin-V, DNA fragmentation) were performed.
- Antigen-presenting cells (APCs) and T-cell lines (TCLs) were incubated with mitoxantrone.
Main Results:
- Mitoxantrone inhibited proliferation of activated PBMCs, B lymphocytes, and antigen-specific TCLs in a dose-dependent manner.
- Mitoxantrone impaired antigen presentation by dendritic cells (DCs).
- Low mitoxantrone concentrations induced apoptosis in PBMCs, monocytes, and DCs; higher doses caused cell lysis.
Conclusions:
- Mitoxantrone's benefits in MS may stem from non-specific cytotoxic effects on lymphocytes.
- Induction of programmed cell death in professional APCs, such as DCs, is another key mechanism.
- These actions contribute to mitoxantrone's immunosuppressive and therapeutic effects in multiple sclerosis.